Clinical Trials Directory

Trials / Completed

CompletedNCT02977117

The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis

The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects With End-Stage Renal Disease Treated With Haemodialysis - A Randomised Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Iain Bressendorff · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to examine the effect of increasing dialyse magnesium on serum calcification propensity in subjects with end-stage renal disease treated with haemodialysis.

Detailed description

Patients with end-stage renal disease (ESRD) have a 20-fold increased risk of cardiovascular mortality compared to the general population. Arterial stiffness, likely due to vascular calcification (VC), has been shown to predict cardiovascular mortality in ESRD. Serum calcification propensity (T50) is a novel biomarker, which is believed to reflect the propensity toward ectopic calcification (e.g. VC). Increasing serum magnesium (sMg) should increase T50, which might in turn reduce the formation of VC in patients with ESRD. A cheap and easy way of achieving this would be to increase the concentration of Mg in the dialysate (dMg) of patients with ESRD treated with haemodialysis (HD). The investigators wish to conduct a randomised controlled double-blind clinical trial to examine whether increasing dMg will improve T50 in subjects with ESRD treated with HD.

Conditions

Interventions

TypeNameDescription
OTHERDialysate magnesium (1.0 mmol/L)Dialysate magnesium will be increased from 0.5 mmol/L to 1.0 mmol/L for 4 weeks after which subjects will return to dialysate magnesium 0.5 mmol/L for 2 weeks observation.
OTHERDialysate magnesium (0.5 mmol/L)Dialysate magnesium will be maintained at 0.5 mmol/L for the duration of the trial.

Timeline

Start date
2016-12-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2016-11-30
Last updated
2018-06-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02977117. Inclusion in this directory is not an endorsement.